Yucca Health

TryYucca (Yucca Health) pricing in 2026: compounded semaglutide starts at $146/month, with a 6-month plan at $875 total ($145.83/month effective rate). Compounded tirzepatide starts at approximately $258/month, with multi-month plans offering lower effective monthly costs. Klarna, Afterpay, and Affirm are all accepted so you can split payments into smaller installments. No insurance is accepted, but HSA/FSA funds may be eligible, confirm with your plan administrator.

Yes. TryYucca (Yucca Health) is a licensed telehealth platform that prescribes compounded semaglutide and tirzepatide through a physician-led clinical review process. Medications are filled at licensed U.S. compounding pharmacies. Compounded GLP-1 medications are not FDA-approved finished products, but they use the same active ingredients (semaglutide, tirzepatide) as their branded counterparts, compounded under state pharmacy board oversight and PCAB-accreditation standards.

TryYucca is the updated brand name for the platform previously known as Yucca Health. The core program, personalized compounded GLP-1 treatment, fast online approval, and home delivery, remains the same. The rebrand reflects an expanded offering that now includes both semaglutide and tirzepatide treatment plans.

Yes, TryYucca (Yucca Health) now offers personalized compounded tirzepatide plans starting at approximately $258/month, in addition to its compounded semaglutide program. Tirzepatide activates both GIP and GLP-1 receptors, which research suggests drives higher average weight loss (15–22% body weight in clinical trials) compared to semaglutide alone (10–15%). Your assigned provider will recommend the most appropriate medication based on your health profile.

The online intake takes approximately 10 minutes. A licensed provider reviews your submission and typically issues a decision within 24 hours. Once approved, your prescription is processed at a licensed U.S. compounding pharmacy and shipped via UPS 2-Day Air on most orders, most patients receive their first shipment within 3–5 business days of completing the intake.

Compounded semaglutide uses the same active ingredient, semaglutide, at clinically equivalent dosing to Ozempic and Wegovy. The difference is the manufacturing source: branded semaglutide is produced by Novo Nordisk in FDA-regulated facilities, while compounded semaglutide is prepared by state-licensed compounding pharmacies. When dosed equivalently, clinical outcomes are expected to be comparable, though the FDA does not individually evaluate compounded medications.

TryYucca (Yucca Health) does not accept health insurance. The platform operates on a direct-pay model, which is standard for compounded GLP-1 programs. To make payments manageable, Klarna, Afterpay, and Affirm are all available at checkout, letting you split treatment costs across multiple smaller payments. Some patients may also be able to use HSA or FSA funds, confirm eligibility with your plan administrator.

TryYucca (Yucca Health) is among the most competitive compounded GLP-1 platforms in 2026. At $146/month for semaglutide and $258/month for tirzepatide, it undercuts Sprout Health ($249/month semaglutide), TMates ($199/month), and most branded alternatives. Compared to Eden ($129/month semaglutide), TryYucca costs slightly more per month but adds three BNPL options and now includes a tirzepatide program. For patients who want both semaglutide and tirzepatide options in one platform at accessible prices, TryYucca is one of the strongest choices available.

Individual results vary based on starting weight, adherence, lifestyle, and medication choice. In the first 1–2 weeks, most patients notice reduced appetite and fewer cravings. By weeks 3–6, appetite suppression becomes more consistent and early weight changes are often visible. By months 3–6 of consistent use, medically supervised GLP-1 therapy (semaglutide or tirzepatide) is associated with 10–22% average body weight reduction in clinical research. TryYucca (Yucca Health) provides ongoing provider support and dosage adjustments to help optimize outcomes throughout treatment.